project id: TCGA-BRCA; case submitter id: TCGA-B6-A40C; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.31; rna integrity number: 8.5; age at index: 51; days to birth: -18852; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 18852; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2164.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 2677; initial weight: 20.0; sample id: e852c16b-cd36-4551-8cc5-8b59719ca987; sample submitter id: TCGA-B6-A40C-01A; portion id: ccb0555f-562c-4796-8e92-2146e7bb104f; portion submitter id: TCGA-B6-A40C-01A-11; slide id: 8b901e88-9348-4988-9f69-c130d7d8e78e; slide submitter id: TCGA-B6-A40C-01A-01-TS1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;